Digital Health, Artificial Intelligence & Internet of Everything
We empower clients to capitalize on Digital Health, AI, and IoE - accelerating success in these emerging fields. Leveraging robust research capabilities, we deliver strategic insights enabling partners to build winning solutions and gain a competitive edge.
We empower Pharma, Biotech, Healthcare and HealthTech/MedTech companies to capitalize on Digital Health, AI and IoE, accelerating their competitive advantage.
As trusted partners, we provide strategic support spanning areas such as:
- Collaborative projects with BioPharma innovation units and patient solution teams
- Intensive patient-centricity research, placing the end-user at the heart of every solution
- Trend analysis in AI, wearable tech, digital therapeutics, and comprehensive digital health solutions
- Creation and support in AI-powered tool development for enhanced data intelligence
- Joint strategy formulation for competitive digital health and AI initiatives
- Pioneering research on the transformative impact of AI/IoE on healthcare, from “smart” homes to “smart” appliances
With robust research and consulting, we deliver evidence-based solutions, enabling clients to implement winning digital strategies.
Ready to accelerate innovation?
Let’s build winning tech strategies together. Contact us at info@lqventures.com.
March 30, 2026
Hematology Today—March 30, 2026
March 30, 2026
Oncology Today—March 30, 2026
March 30, 2026
AI in Healthcare and Digital Health Today—March 30, 2026
March 30, 2026
Lucid Diligence Brief: InSilico Medicine and Lilly global partnership
March 29, 2026
Lucid Diligence Brief: Otsuka to acquire Transcend Therapeutics
March 27, 2026
Lucid Diligence Brief: Pinnacle Medicines $89 million Series B
March 27, 2026
Respiratory Today—March 27, 2026
March 27, 2026
Vaccines Today—March 27, 2026
March 27, 2026
Public Health Today—March 27, 2026
March 26, 2026